/MODTX.ST
MODTX.ST Stock - Modus Therapeutics Holding AB (publ)
Healthcare|BiotechnologySTO
$0.30-7.48%
$0.02 (-7.48%) • Dec 23
55
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.33
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for MODTX.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.29 – $0.30
TARGET (TP)$0.34
STOP LOSS$0.27
RISK/REWARD1:1.6
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.26
52W High$5.00
52W Low$0.27
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-15,838,000 | $-16,401,000 | $-18,006,000 | $-20,690,000 | $-6,020,000 |
| Net Income | $-15,545,000 | $-17,897,000 | $-18,320,000 | $-20,691,000 | $-6,019,000 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-0.43 | $-1.01 | $-1.14 | $-1.67 | $-0.37 |
Company Overview
Modus Therapeutics Holding AB (publ), a biotechnology company, develops a treatment for sepsis and septic shock in Sweden. Its lead product is Sevuparin, a polysaccharide to treat patients with sepsis and septic shock, which is under Phase Ib clinical study. The company was founded in 2011 and is headquartered in Stockholm, Sweden.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
MODTX.STBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.08
Q2 2025
EPS Surprise History
Q3 23
No data
Q4 23
No data
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2025 | May 14, 2025 | — | $-0.08 | — | — |
Q1 2025 | Feb 20, 2025 | — | $-0.13 | — | — |
Q4 2024 | Nov 20, 2024 | — | $-0.08 | — | — |
Q3 2024 | Aug 23, 2024 | — | $-0.13 | — | — |
Q2 2024 | May 14, 2024 | — | $-0.09 | — | — |
Q1 2024 | Feb 21, 2024 | — | $-0.18 | — | — |
Q4 2023 | Nov 8, 2023 | — | $-0.19 | — | — |
Q3 2023 | Aug 23, 2023 | — | $-0.29 | — | — |
Q2 2023 | May 9, 2023 | — | $-0.38 | — | — |
Q1 2023 | Feb 22, 2023 | — | $-0.58 | — | — |
Q4 2022 | Nov 22, 2022 | — | $-0.18 | — | — |
Q3 2022 | Aug 23, 2022 | — | $-0.19 | — | — |
Q2 2022 | May 16, 2022 | — | $-0.19 | — | — |
Q1 2022 | Feb 22, 2022 | — | $-0.76 | — | — |
Q4 2021 | Nov 18, 2021 | — | $-0.30 | — | — |
Q3 2021 | Aug 20, 2021 | — | $-0.16 | — | — |
Q2 2021 | May 7, 2021 | — | $-0.09 | — | — |
Q2 2021 | Apr 14, 2021 | — | $-0.06 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.04 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.11 | — | — |
Latest News
Loading news...
Frequently Asked Questions about MODTX.ST
What is MODTX.ST's current stock price?
Modus Therapeutics Holding AB (publ) (MODTX.ST) is currently trading at $0.30 per share. The stock has moved -7.48% today.
What is the analyst price target for MODTX.ST?
No analyst price targets are currently available for this stock.
What sector is Modus Therapeutics Holding AB (publ) in?
Modus Therapeutics Holding AB (publ) operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the STO exchange.
What is MODTX.ST's market cap?
Modus Therapeutics Holding AB (publ) has a market capitalization of $0.03 billion, making it a small-cap company.
Does MODTX.ST pay dividends?
No, Modus Therapeutics Holding AB (publ) does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare Sector2CUREX.ST
2cureX AB (publ)
$0.75
Mkt Cap: $0.0B
AINO.ST
Aino Health AB (publ)
$0.18
Mkt Cap: $0.0B
EPIS-B.ST
Episurf Medical AB (publ)
$0.03
Mkt Cap: $0.0B
EXPRS2.ST
ExpreS2ion Biotech Holding AB (publ)
$16.92
Mkt Cap: $0.0B
FLUI.ST
Fluicell AB (publ)
$11.30
Mkt Cap: $0.0B
GUARD.ST
Guard Therapeutics International AB (publ)
$1.40
Mkt Cap: $0.0B
LPGO.ST
Lipigon Pharmaceuticals AB (publ)
$0.01
Mkt Cap: $0.0B
QLIFE.ST
Qlife Holding AB (publ)
$2.40
Mkt Cap: $0.0B
SIMRIS-B.ST
Simris Alg AB (publ)
$0.05
Mkt Cap: $0.0B
STABL.ST
Stayble Therapeutics AB (publ)
$0.21
Mkt Cap: $0.0B
Explore stocks similar to MODTX.ST for comparison